share_log
Moomoo 24/7 ·  Mar 13 13:40
ClearPoint Neuro Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Financial Results and Reaffirmed FY24 Revenue Guidance. Also, Stifel Reiterated a Buy Rating on the Stock and Raised Its Price Target From $8 to $9
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment